<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-11-19">November 19, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Huong</forename><forename type="middle">D</forename><surname>Meeks</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Honglin</forename><surname>Song</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kyriaki</forename><surname>Michailidou</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Manjeet</forename><forename type="middle">K</forename><surname>Bolla</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Joe</forename><surname>Dennis</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Qin</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Barrowdale</surname></persName>
						</author>
						<author>
							<persName><roleName>EMBRACE</roleName><forename type="first">Debra</forename><surname>Frost</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lesley</forename><surname>Mcguffog</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Steve</forename><surname>Ellis</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bingjian</forename><surname>Feng</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Saundra</forename><forename type="middle">S</forename><surname>Buys</surname></persName>
						</author>
						<author>
							<persName><forename type="first">John</forename><forename type="middle">L</forename><surname>Hopper</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Melissa</forename><forename type="middle">C</forename><surname>Southey</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Tesoriero</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><forename type="middle">A</forename><surname>James</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fiona</forename><surname>Bruinsma</surname></persName>
						</author>
						<author>
							<persName><roleName>Australia</roleName><forename type="first">Ian</forename><forename type="middle">G</forename><surname>Campbell</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ovarian</forename><surname>Cancer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Study</forename><surname>Group</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Annegien</forename><surname>Broeks</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marjanka</forename><forename type="middle">K</forename><surname>Schmidt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Frans</forename><forename type="middle">B L</forename><surname>Hogervorst</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Matthias</forename><forename type="middle">W</forename><surname>Hebon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">A</forename><surname>Beckman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Olivia</forename><surname>Fasching</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nichola</forename><surname>Fletcher</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elinor</forename><forename type="middle">J</forename><surname>Johnson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elio</forename><surname>Sawyer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susana</forename><surname>Riboli</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Usha</forename><surname>Banerjee</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ian</forename><surname>Menon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Barbara</forename><surname>Tomlinson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ute</forename><surname>Burwinkel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Frederik</forename><surname>Hamann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anja</forename><surname>Marme</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ramunas</forename><surname>Rudolph</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Laima</forename><surname>Janavicius</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nadine</forename><surname>Tihomirova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Judy</forename><surname>Tung</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Garber</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kathryn</forename><forename type="middle">L</forename><surname>Cramer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elizabeth</forename><forename type="middle">M</forename><surname>Terry</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Shelley</forename><forename type="middle">S</forename><surname>Poole</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Cecilia</forename><forename type="middle">M</forename><surname>Tworoger</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elizabeth</forename><forename type="middle">J</forename><surname>Dorfling</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><forename type="middle">K</forename><surname>Van Rensburg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Pascal</forename><surname>Godwin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thérèse</forename><surname>Guénel</surname></persName>
						</author>
						<author>
							<persName><roleName>GEMO Study Collaborators</roleName><forename type="first">Dominique</forename><surname>Truong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Francesca</forename><surname>Stoppa-Lyonnet</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sylvie</forename><surname>Damiola</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Olga</forename><forename type="middle">M</forename><surname>Mazoyer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Claudine</forename><surname>Sinilnikova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Isaacs</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Stig</forename><forename type="middle">E</forename><surname>Maugard</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Henrik</forename><surname>Bojesen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anne-Marie</forename><surname>Flyger</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">V O</forename><surname>Gerdes</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Allen</forename><surname>Hansen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susanne</forename><forename type="middle">K</forename><surname>Jensen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Claus</forename><surname>Kjaer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Estrid</forename><surname>Hogdall</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Inge</forename><forename type="middle">Sokilde</forename><surname>Hogdall</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mads</forename><surname>Pedersen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Javier</forename><surname>Thomassen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Benitez</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ana</forename><surname>González-Neira</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Miguel</forename><surname>Osorio</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Pedro</forename><forename type="middle">Perez</forename><surname>De La Hoya</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Orland</forename><surname>Segura</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Conxi</forename><surname>Diez</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Joan</forename><surname>Lazaro</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hoda</forename><surname>Brunet</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lee</forename><surname>Anton-Culver</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Esther</forename><forename type="middle">M</forename><surname>Eunjung</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">L</forename><surname>John</surname></persName>
						</author>
						<author>
							<persName><surname>Neuhausen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Chun</forename><surname>Yuan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Danielle</forename><surname>Ding</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jeffrey</forename><forename type="middle">N</forename><surname>Castillo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Patricia</forename><forename type="middle">A</forename><surname>Weitzel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><forename type="middle">L</forename><surname>Ganz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Salina</forename><forename type="middle">B</forename><surname>Nussbaum</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Beth</forename><forename type="middle">Y</forename><surname>Chan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jenny</forename><surname>Karlan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Lester</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Simon</forename><surname>Wu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">J</forename><surname>Gayther</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Weiva</forename><surname>Ramus</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alice</forename><forename type="middle">S</forename><surname>Sieh</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alvaro</forename><forename type="middle">N A</forename><surname>Whittermore</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Catherine</forename><forename type="middle">M</forename><surname>Monteiro</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">Beth</forename><surname>Phelan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marion</forename><surname>Terry</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kenneth</forename><surname>Piedmonte</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><surname>Offit</surname></persName>
						</author>
						<author>
							<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Robson</surname></persName>
						</author>
						<author>
							<persName><surname>Meeks</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Douglas</forename><surname>Levine</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kirsten</forename><forename type="middle">B</forename><surname>Moysich</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rikki</forename><surname>Cannioto</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sara</forename><forename type="middle">H</forename><surname>Olson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">B</forename><surname>Daly</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Katherine</forename><forename type="middle">L</forename><surname>Nathanson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><forename type="middle">M</forename><surname>Domchek</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karen</forename><forename type="middle">H</forename><surname>Lu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Dong</forename><surname>Liang</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michelle</forename><forename type="middle">A T</forename><surname>Hildebrant</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Roberta</forename><surname>Ness</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Francesmary</forename><surname>Modugno</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Leigh</forename><surname>Pearce</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><forename type="middle">T</forename><surname>Goodman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Pamela</forename><forename type="middle">J</forename><surname>Thompson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hermann</forename><surname>Brenner</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Katja</forename><surname>Butterbach</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alfons</forename><surname>Meindl</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Eric</forename><surname>Hahnen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Barbara</forename><surname>Wappenschmidt</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hiltrud</forename><surname>Brauch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Brüning</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Carl</forename><surname>Blomqvist</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sofia</forename><surname>Khan</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Heli</forename><surname>Nevanlinna</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Liisa</forename><forename type="middle">M</forename><surname>Pelttari</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kristiina</forename><surname>Aittomäki</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ralf</forename><surname>Butzow</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Natalia</forename><forename type="middle">V</forename><surname>Bogdanova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thilo</forename><surname>Dörk</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Annika</forename><surname>Lindblom</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sara</forename><surname>Margolin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Johanna</forename><surname>Rantala</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Veli-Matti</forename><surname>Kosma</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Arto</forename><surname>Mannermaa</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Diether</forename><surname>Lambrechts</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Neven</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kathleen</forename><forename type="middle">B M</forename><surname>Claes</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Tom</forename><surname>Van Maerken</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jenny</forename><surname>Chang-Claude</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Dieter</forename><surname>Flesch-Janys</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><surname>Heitz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Raymonda</forename><surname>Varon-Mateeva</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Paolo</forename><surname>Peterlongo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Paolo</forename><surname>Radice</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alessandra</forename><surname>Viel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Monica</forename><surname>Barile</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bernard</forename><surname>Peissel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Siranoush</forename><surname>Manoukian</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Montagna</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Cristina</forename><surname>Oliani</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ana</forename><surname>Peixoto</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><forename type="middle">R</forename><surname>Teixeira</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anita</forename><surname>Collavoli</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Emily</forename><surname>Hallberg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Janet</forename><forename type="middle">E</forename><surname>Olson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ellen</forename><forename type="middle">L</forename><surname>Goode</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Steven</forename><forename type="middle">N</forename><surname>Hart</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hermela</forename><surname>Shimelis</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Julie</forename><forename type="middle">M</forename><surname>Cunningham</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Graham</forename><forename type="middle">G</forename><surname>Giles</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Roger</forename><forename type="middle">L</forename><surname>Milne</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sue</forename><surname>Healey</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kathy</forename><surname>Tucker</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christopher</forename><forename type="middle">A</forename><surname>Haiman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Brian</forename><forename type="middle">E</forename><surname>Henderson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><forename type="middle">S</forename><surname>Goldberg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><surname>Tischkowitz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jacques</forename><surname>Simard</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Penny</forename><surname>Soucy</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Diana</forename><forename type="middle">M</forename><surname>Eccles</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nhu</forename><surname>Le</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anne-Lise</forename><surname>Borresen-Dale</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Vessela</forename><surname>Kristensen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Helga</forename><forename type="middle">B</forename><surname>Salvesen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Line</forename><surname>Bjorge</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elisa</forename><forename type="middle">V</forename><surname>Bandera</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Harvey</forename><surname>Risch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Wei</forename><surname>Zheng</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alicia</forename><surname>Beeghly-Fadiel</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hui</forename><surname>Cai</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Katri</forename><surname>Pylkäs</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><forename type="middle">A E M</forename><surname>Tollenaar</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ans</forename><forename type="middle">M W</forename><surname>Van Der Ouweland</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Irene</forename><forename type="middle">L</forename><surname>Andrulis</surname></persName>
						</author>
						<author>
							<persName><roleName>OCGN</roleName><forename type="first">Julia</forename><forename type="middle">A</forename><surname>Knight</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Steven</forename><surname>Narod</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Devilee</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><surname>Winqvist</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jonine</forename><surname>Figueroa</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><forename type="middle">H</forename><surname>Greene</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Phuong</forename><forename type="middle">L</forename><surname>Mai</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jennifer</forename><forename type="middle">T</forename><surname>Loud</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Montserrat</forename><surname>García-Closas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Minouk</forename><forename type="middle">J</forename><surname>Schoemaker</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Kamila</forename><surname>Czene</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Hatef</forename><surname>Darabi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Iain</forename><surname>Mcneish</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nadeem</forename><surname>Siddiquil</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Rosalind</forename><surname>Glasspool</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ava</forename><surname>Kwong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sue</forename><forename type="middle">K</forename><surname>Park</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Soo</forename><forename type="middle">Hwang</forename><surname>Teo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sook-Yee</forename><surname>Yoon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Keitaro</forename><surname>Matsuo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Satoyo</forename><surname>Hosono</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yin</forename><forename type="middle">Ling</forename><surname>Woo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yu-Tang</forename><surname>Gao</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lenka</forename><surname>Foretova</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><forename type="middle">F</forename><surname>Singer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Rappaport-Feurhauser</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Eitan</forename><surname>Friedman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Yael</forename><surname>Laitman</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Gad</forename><surname>Rennert</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Evgeny</forename><forename type="middle">N</forename><surname>Imyanitov</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><forename type="middle">J</forename><surname>Hulick</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Olufunmilayo</forename><forename type="middle">I</forename><surname>Olopade</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Leigha</forename><surname>Senter</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Edith</forename><surname>Olah</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jennifer</forename><forename type="middle">A</forename><surname>Doherty</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Joellen</forename><surname>Schildkraut</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Linetta</forename><forename type="middle">B</forename><surname>Koppert</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lambertus</forename><forename type="middle">A</forename><surname>Kiemeney</surname></persName>
						</author>
						<author>
							<persName><forename type="first">F</forename><forename type="middle">A G</forename><surname>Leon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Linda</forename><forename type="middle">S</forename><surname>Massuger</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Tanja</forename><surname>Cook</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jingmei</forename><surname>Pejovic</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ake</forename><surname>Li</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Borg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mary</forename><forename type="middle">Anne</forename><surname>Öfverholm</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Nicolas</forename><surname>Rossing</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Wentzensen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Angela</forename><surname>Henriksson</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Simon</forename><forename type="middle">S</forename><surname>Cox</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Barbara</forename><forename type="middle">J</forename><surname>Cross</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mitul</forename><surname>Pasini</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Shah</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Diana</forename><surname>Kabisch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anna</forename><surname>Torres</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><surname>Jakubowska</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jacek</forename><surname>Lubinski</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bjarni</forename><forename type="middle">A</forename><surname>Gronwald</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jolanta</forename><surname>Agnarsson</surname></persName>
						</author>
						<author>
							<persName><surname>Kupryjanczyk</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Joanna</forename><surname>Moes-Sosnowska</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Florentia</forename><surname>Fostira</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Irene</forename><surname>Konstantopoulou</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><surname>Slager</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Jones</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Antonis</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrew</forename><surname>Berchuck</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Anthony</forename><surname>Swerdlow</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Georgia</forename><surname>Chenevix-Trench</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alison</forename><forename type="middle">M</forename><surname>Dunning</surname></persName>
						</author>
						<author>
							<persName><roleName>Per</roleName><forename type="first">Paul</forename><forename type="middle">D P</forename><surname>Pharoah</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Douglas</forename><forename type="middle">F</forename><surname>Hall</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fergus</forename><forename type="middle">J</forename><surname>Easton</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Amanda</forename><forename type="middle">B</forename><surname>Couch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">E</forename><surname>Spurdle</surname></persName>
						</author>
						<author>
							<persName><surname>Goldgar</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Peter</forename><surname>Maccallum</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>PhD</roleName><forename type="first">David</forename><forename type="middle">E</forename><surname>Goldgar</surname></persName>
							<email>david.goldgar@hsc.utah.edu</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Cancer Control and Population Sciences</orgName>
								<orgName type="institution" key="instit2">Huntsman Cancer Institute</orgName>
								<orgName type="institution" key="instit3">University of Utah</orgName>
								<address>
									<settlement>Salt Lake City</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution" key="instit1">UT (HDM, DEG)</orgName>
								<orgName type="institution" key="instit2">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<region>HSo</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">DFE)</orgName>
								<orgName type="laboratory">Centre for Cancer Genetic Epidemiology</orgName>
								<orgName type="institution">BJP</orgName>
								<address>
									<region>MS, AMD, PDPP</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Department of Public Health and Primary Care</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution" key="instit1">Huntsman Cancer Institute</orgName>
								<orgName type="institution" key="instit2">University of Utah School of Medicine</orgName>
								<address>
									<settlement>Salt Lake City</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">UT (SSB)</orgName>
								<orgName type="department" key="dep3">Melbourne School of Population and Global Health</orgName>
								<orgName type="laboratory">Centre for Epidemiology and Biostatistics</orgName>
								<orgName type="institution" key="instit1">UT (BF, DEG)</orgName>
								<orgName type="institution" key="instit2">Huntsman Cancer Institute</orgName>
								<orgName type="institution" key="instit3">University of Utah School of Medicine</orgName>
								<address>
									<settlement>Salt Lake City</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">the University of Melbourne</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="laboratory">Genetic Epidemiology Laboratory</orgName>
								<orgName type="institution">the University of Melbourne</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Victoria, Australia (MCS)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Parkville</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Familial Cancer Centre</orgName>
								<orgName type="department" key="dep2">Department of Oncology</orgName>
								<orgName type="laboratory">PAJ</orgName>
								<orgName type="institution">Kathleen Cuningham Consortium for Research into Familial Breast Cancer -Peter MacCallum Cancer Center</orgName>
								<address>
									<addrLine>Peter MacCallum Cancer Center</addrLine>
									<settlement>Melbourne, Melbourne</settlement>
									<region>Victoria, Australia (kConFab), Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="institution">the University of Melbourne</orgName>
								<address>
									<settlement>Melbourne</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">PAJ</orgName>
								<orgName type="department" key="dep2">Cancer Epidemiology Centre</orgName>
								<address>
									<addrLine>Cancer Council Victoria</addrLine>
									<settlement>Melbourne</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Oncology</orgName>
								<orgName type="department" key="dep2">Peter MacCallum Cancer Centre</orgName>
								<orgName type="institution">University of Melbourne</orgName>
								<address>
									<settlement>Parkville</settlement>
									<region>Victoria</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="institution">IGC</orgName>
								<address>
									<addrLine>Cancer Division</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">AOCSG, SHe</orgName>
								<orgName type="department" key="dep2">GCT)</orgName>
								<orgName type="institution">QIMR Berghofer Medical Research Institute</orgName>
								<address>
									<settlement>Brisbane</settlement>
									<region>Queensland</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">AOCSG</orgName>
								<orgName type="institution">Peter MacCallum Cancer Institute</orgName>
								<address>
									<settlement>East Melbourne, Victoria</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="institution" key="instit1">Netherlands Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Antoni van Leeuwenhoek Hospital</orgName>
								<address>
									<settlement>Amsterdam</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="department">FBLH)</orgName>
								<orgName type="laboratory">The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) Coordinating Center</orgName>
								<orgName type="institution" key="instit1">the Netherlands (ABr, MKS)</orgName>
								<orgName type="institution" key="instit2">Family Cancer Clinic</orgName>
								<orgName type="institution" key="instit3">Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country>the Netherlands (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="department">Department of Gynaecology and Ostetrics</orgName>
								<orgName type="institution">Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country>the Netherlands (HEBON</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="department" key="dep1">Comprehensive Cancer Center Erlangen-EMN</orgName>
								<orgName type="department" key="dep2">PAF)</orgName>
								<orgName type="department" key="dep3">Division of Hematology and Oncology</orgName>
								<orgName type="department" key="dep4">Department of Medicine</orgName>
								<orgName type="department" key="dep5">David Geffen School of Medicine</orgName>
								<orgName type="institution" key="instit1">University Hospital Erlangen</orgName>
								<orgName type="institution" key="instit2">Friedrich-Alexander University Erlangen-Nuremberg</orgName>
								<address>
									<settlement>Erlangen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="department" key="dep1">Division of Breast Cancer Research and Breakthrough Breast Cancer Research Centre</orgName>
								<orgName type="department" key="dep2">Institute of Cancer Research</orgName>
								<orgName type="department" key="dep3">Division of Cancer Studies</orgName>
								<orgName type="laboratory">Research Oncology</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>Los Angeles, Los Angeles, London</settlement>
									<region>CA (PAF), OF, NJ, AS)</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">School of Public Health</orgName>
								<orgName type="laboratory">EJS</orgName>
								<orgName type="institution" key="instit1">King&apos;s College London</orgName>
								<orgName type="institution" key="instit2">Guy&apos;s Hospital</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="institution">Imperial College</orgName>
								<address>
									<settlement>London</settlement>
									<region>UK (ER)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department">(SB); Women&apos;s Cancer</orgName>
								<orgName type="institution">The Royal Marsden NHS Foundation Trust</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="laboratory">Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre</orgName>
								<orgName type="institution">University College London Elizabeth Garrett Anderson (EGA) Institute for Women&apos;s Health</orgName>
								<address>
									<settlement>London</settlement>
									<region>UK (UM)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department">Division of Molecular Genetic Epidemiology</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="department">(BB); Molecular Genetics of Breast Cancer</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff27">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg, Germany</settlement>
									<region>UH, MK, DT)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff28">
								<orgName type="department">National Center for Tumor Diseases</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country>Germany (FMa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff29">
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<settlement>Heidelberg</settlement>
									<country>Germany (FMa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff30">
								<orgName type="department">Division of Cancer Epidemiology</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff31">
								<orgName type="department" key="dep1">Latvian Biomedical Research and Study Centre</orgName>
								<orgName type="department" key="dep2">Department of Medical Oncology</orgName>
								<orgName type="institution">JCC); State Research Institute Centre for Innovative Medicine</orgName>
								<address>
									<settlement>Vilnius, Riga</settlement>
									<region>Lithuania (RJ), Latvia (LT)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff32">
								<orgName type="institution">Beth Israel Deaconess Medical Center</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA (NT)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff33">
								<orgName type="department" key="dep1">Dana-Farber Cancer Institute</orgName>
								<orgName type="department" key="dep2">Obstetrics and Gynecology Epidemiology Center</orgName>
								<orgName type="institution">Cancer Risk and Prevention Clinic</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA (JGa)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff34">
								<orgName type="institution">Brigham and Women&apos;s Hospital</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA (DCr</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff35">
								<orgName type="department" key="dep1">Channing Division of Network Medicine</orgName>
								<orgName type="department" key="dep2">Brigham and Women&apos;s Hospital</orgName>
								<orgName type="institution" key="instit1">KLT)</orgName>
								<orgName type="institution" key="instit2">Harvard Medical School</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA (EMP</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff36">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">SST)</orgName>
								<orgName type="department" key="dep3">Department of Genetics</orgName>
								<orgName type="institution" key="instit1">SST, ABS)</orgName>
								<orgName type="institution" key="instit2">Harvard School of Public Health</orgName>
								<address>
									<settlement>Boston</settlement>
									<region>MA (EMP</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff37">
								<orgName type="institution">University of Pretoria</orgName>
								<address>
									<settlement>Pretoria</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff38">
								<orgName type="department" key="dep1">Department of Pathology and Laboratory Medicine</orgName>
								<orgName type="department" key="dep2">Medical Center</orgName>
								<orgName type="institution" key="instit1">South Africa (CMD, EJvR)</orgName>
								<orgName type="institution" key="instit2">University of Kansas</orgName>
								<address>
									<settlement>Kansas City</settlement>
									<region>KS (AKG)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff39">
								<orgName type="department" key="dep1">Center for Research in Epidemiology and Population Health (CESP)</orgName>
								<orgName type="department" key="dep2">Environmental Epidemiology of Cancer</orgName>
								<orgName type="department" key="dep3">TT)</orgName>
								<orgName type="institution">National Institute of Health and Medical Research (INSERM) U1018</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<region>PG</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff40">
								<orgName type="department">TT)</orgName>
								<orgName type="institution">University Paris-Sud</orgName>
								<address>
									<settlement>Villejuif</settlement>
									<region>PG</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff41">
								<orgName type="department" key="dep1">GEMO</orgName>
								<orgName type="department" key="dep2">Institut Curie</orgName>
								<orgName type="institution" key="instit1">GEMO study: National Cancer Genetics Network</orgName>
								<orgName type="institution" key="instit2">UNICANCER Genetic Group</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff42">
								<orgName type="department">Department of Tumour Biology</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France (DSL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff43">
								<orgName type="department" key="dep1">Institute Curie</orgName>
								<orgName type="department" key="dep2">INSERM U830</orgName>
								<orgName type="institution">Université Paris Descartes</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France (DSL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff44">
								<orgName type="department">INSERM U1052</orgName>
								<orgName type="institution">Sorbonne Paris Cité</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France (DSL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff45">
								<orgName type="department">Centre de Recherche en Cancérologie de Lyon</orgName>
								<orgName type="laboratory">UMR 5286</orgName>
								<orgName type="institution" key="instit1">CNRS</orgName>
								<orgName type="institution" key="instit2">Université Lyon</orgName>
								<address>
									<addrLine>SMaz, OMS)</addrLine>
									<settlement>Lyon</settlement>
									<region>FD</region>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff46">
								<orgName type="department">Lombardi Comprehensive Cancer Center</orgName>
								<orgName type="institution" key="instit1">Unité Mixte de Génétique Constitutionelle des Cancers Fréquents</orgName>
								<orgName type="institution" key="instit2">Hospices Civils de Pyon -Centre Léon Bérard</orgName>
								<address>
									<settlement>Lyon</settlement>
									<country>France (OMS</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff47">
								<orgName type="laboratory">Laboratoire de diagnostic génétique et Service d&apos;Onco-hématologie</orgName>
								<orgName type="institution">Georgetown University</orgName>
								<address>
									<settlement>Washington</settlement>
									<region>DC (CI)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff48">
								<orgName type="department">Faculty of Health and Medical Sciences</orgName>
								<orgName type="institution" key="instit1">Hopitaux Universitaire de Strasbourg</orgName>
								<orgName type="institution" key="instit2">CHRU Nouvel Hôpital Civil</orgName>
								<address>
									<settlement>Strasbourg</settlement>
									<region>CM)</region>
									<country>France (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff49">
								<orgName type="department">Department of Clinical Biochemistry</orgName>
								<orgName type="institution">University of Copenhagen</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country>Denmark (SEB</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff50">
								<orgName type="department">Department of Breast Surgery</orgName>
								<orgName type="institution" key="instit1">Herlev Hospital</orgName>
								<orgName type="institution" key="instit2">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Herlev</settlement>
									<country>Denmark (SEB</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff51">
								<orgName type="department">Department of Clinical Genetics, Rigshospitalet</orgName>
								<orgName type="institution" key="instit1">Herlev Hospital</orgName>
								<orgName type="institution" key="instit2">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Herlev</settlement>
									<region>Denmark (HF)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff52">
								<orgName type="department">Center for Genomic Medicine</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Copenhagen, Rigshospitalet</settlement>
									<country>Denmark (AMG</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff53">
								<orgName type="department" key="dep1">Department of Virus, Lifestyle and Genes</orgName>
								<orgName type="department" key="dep2">Danish Cancer Society Research Center</orgName>
								<orgName type="institution">Copenhagen University Hospital</orgName>
								<address>
									<settlement>Copenhagen, Copenhagen</settlement>
									<region>AJe</region>
									<country>Denmark (TVOH), Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff54">
								<orgName type="department" key="dep1">Department of Gynecology, Rigshospitalet</orgName>
								<orgName type="department" key="dep2">Department of Pathology</orgName>
								<orgName type="laboratory">(SKK, CH); Molecular Unit</orgName>
								<orgName type="institution" key="instit1">SKK, EHo)</orgName>
								<orgName type="institution" key="instit2">University of Copenhagen</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff55">
								<orgName type="department">Section of Molecular Diagnostics</orgName>
								<orgName type="institution" key="instit1">Herlev Hospital</orgName>
								<orgName type="institution" key="instit2">University of Copenhagen</orgName>
								<address>
									<settlement>Copenhagen</settlement>
									<country>Denmark (EHo</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff56">
								<orgName type="department">Department of Biochemistry</orgName>
								<orgName type="institution">Aalborg University Hospital</orgName>
								<address>
									<settlement>Aalborg</settlement>
									<country>Denmark (ISP</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff57">
								<orgName type="department" key="dep1">Department of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Human Cancer Genetics Program</orgName>
								<orgName type="department" key="dep3">Spanish National Cancer Centre (CNIO)</orgName>
								<orgName type="laboratory">Human Genetics Group</orgName>
								<orgName type="institution" key="instit1">Odense University Hospital</orgName>
								<orgName type="institution" key="instit2">Odense C, Denmark (MTh)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff58">
								<orgName type="department" key="dep1">Human Cancer Genetics Program</orgName>
								<orgName type="department" key="dep2">Spanish National Cancer Centre (CNIO)</orgName>
								<orgName type="laboratory">JBe, AO); Human Genotyping Unit (CEGEN)</orgName>
								<orgName type="institution">Biomedical Network on Rare Diseases (CIBERER)</orgName>
								<address>
									<settlement>Madrid, Madrid</settlement>
									<country>Spain (JBe, AGN), Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff59">
								<orgName type="department" key="dep1">JBe, AO)</orgName>
								<orgName type="department" key="dep2">Department of Oncology</orgName>
								<orgName type="laboratory">Molecular Oncology Laboratory</orgName>
								<orgName type="institution" key="instit1">Hospital Clinico San Carlos</orgName>
								<orgName type="institution" key="instit2">IdISSC (Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos) (MdlH)</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff60">
								<orgName type="department">Oncogenetics Group</orgName>
								<orgName type="institution">Hospital Clinico San Carlos, IdISSC</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country>Spain (PPS</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff61">
								<orgName type="department">Institute of Oncology (VHIO)</orgName>
								<orgName type="institution">University Hospital Vall d&apos;Hebron</orgName>
								<address>
									<addrLine>Vall d&apos;Hebron</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff62">
								<orgName type="laboratory">Molecular Diagnostic Unit, Hereditary Cancer Program</orgName>
								<orgName type="institution">Universitat Autònoma de Barcelona</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<region>OD)</region>
									<country>Spain (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff63">
								<orgName type="laboratory">Genetic Counseling Unit, Hereditary Cancer Program</orgName>
								<orgName type="institution">IDIBELL (Bellvitge Biomedical Research Institute)-Catalan Institute of Oncology</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<region>Spain (CL)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff64">
								<orgName type="department" key="dep1">Department of Epidemiology</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">IDIBGI (Institut d&apos;Investigacio Biomedica de Girona)-Catalan Institute of Oncology</orgName>
								<address>
									<settlement>Girona</settlement>
									<country>Spain (JBr</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff65">
								<orgName type="department" key="dep1">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep2">Keck School of Medicine</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>Irvine</settlement>
									<region>CA (HAC)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff66">
								<orgName type="institution">University of Southern California Norris Comprehensive Cancer Center</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff67">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Cancer Prevention Institute of California</orgName>
								<address>
									<settlement>Fremont</settlement>
									<region>California (EMJ)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff68">
								<orgName type="department">Department of Population Sciences</orgName>
								<orgName type="institution">Beckman Research Institute of City of Hope</orgName>
								<address>
									<settlement>Duarte</settlement>
									<region>CA (SLN, YCD)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff69">
								<orgName type="department">Clinical Cancer Genetics</orgName>
								<orgName type="institution">City of Hope Clinical Cancer Genetics Community Research Network</orgName>
								<address>
									<settlement>Duarte</settlement>
									<region>CA (DCa</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff70">
								<orgName type="department" key="dep1">Division of Cancer Prevention and Control Research</orgName>
								<orgName type="department" key="dep2">Jonsson Comprehensive Cancer Center</orgName>
								<orgName type="department" key="dep3">Department of Medicine and Genetics</orgName>
								<orgName type="institution" key="instit1">JNW)</orgName>
								<orgName type="institution" key="instit2">UCLA Schools of Medicine and Public Health</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA (PAG)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff71">
								<orgName type="department">Helen Diller Family Cancer Center</orgName>
								<orgName type="institution">University of California</orgName>
								<address>
									<addrLine>Cancer Risk Program</addrLine>
									<settlement>San Francisco</settlement>
									<region>CA (RLN)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff72">
								<orgName type="institution">University of California</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff73">
								<orgName type="department">Cedars-Sinai Medical Center</orgName>
								<orgName type="institution">Samuel Oschin Comprehensive Cancer Institute</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA (BYK</region>
									<country>JLe</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff74">
								<orgName type="department" key="dep1">Department of Health Research and Policy-Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Cancer Epidemiology</orgName>
								<orgName type="institution">Stanford University of Medicine</orgName>
								<address>
									<settlement>Stanford</settlement>
									<region>CA (WS, ASW)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff75">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">Moffitt Cancer Center</orgName>
								<address>
									<settlement>Tampa</settlement>
									<region>FL (ANAM, CMP)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff76">
								<orgName type="department">Mailman School of Public Health</orgName>
								<orgName type="institution">Columbia University</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY (MBT)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff77">
								<orgName type="department" key="dep1">NRG Oncology Statistics and Data Management Center</orgName>
								<orgName type="department" key="dep2">Roswell Park Center Institute</orgName>
								<address>
									<settlement>Buffalo</settlement>
									<region>NY (MP)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff78">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY (KO, MR)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff79">
								<orgName type="department" key="dep1">Gynecology Service</orgName>
								<orgName type="department" key="dep2">Department of Surgery</orgName>
								<orgName type="institution">Memorial Sloan Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY (DLe)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff80">
								<orgName type="department">Department of Cancer Prevention and Control</orgName>
								<orgName type="institution">Roswell Park Cancer Institute</orgName>
								<address>
									<settlement>Buffalo</settlement>
									<region>NY (KBM, RC)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff81">
								<orgName type="department">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="institution">Memorial Sloan Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY (SHO)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff82">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Fox Chase Cancer Center</orgName>
								<address>
									<settlement>Philadelphia, Basser Center</settlement>
									<region>PA (MBD)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff83">
								<orgName type="department" key="dep1">Abramson Cancer Center</orgName>
								<orgName type="department" key="dep2">Perelman School of Medicine</orgName>
								<orgName type="department" key="dep3">PA (KLN, SMD)</orgName>
								<orgName type="department" key="dep4">Department of Gynecologic Oncology</orgName>
								<orgName type="institution" key="instit1">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit2">University of Texas MD Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX (KHL)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff84">
								<orgName type="department">College of Pharmacy and Health Sciences</orgName>
								<orgName type="institution">Texas Southern University</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX (DLi)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff85">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Texas MD Anderson Cancer Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX (MATH)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff86">
								<orgName type="department">Department of Obstetrics, Gynecology and Reproductive Sciences</orgName>
								<orgName type="institution">University of Texas School of Public Health</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX (RN)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff87">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University of Pittsburgh School of Medicine</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>PA (FMo)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff88">
								<orgName type="department">Graduate School of Public Health</orgName>
								<orgName type="institution">University of Pittsburgh</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>PA (FMo)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff89">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution" key="instit1">Womens Cancer Research Program</orgName>
								<orgName type="institution" key="instit2">Magee-Womens Research Institute and University of Pittsburgh Cancer Institute</orgName>
								<address>
									<settlement>Pittsburgh</settlement>
									<region>PA (FMo)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff90">
								<orgName type="department">School of Public Health</orgName>
								<orgName type="institution">University of Michigan</orgName>
								<address>
									<settlement>Ann Arbor</settlement>
									<region>MI (LP)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff91">
								<orgName type="department">Cedars-Sinai Medical Center</orgName>
								<orgName type="institution" key="instit1">Cancer Prevention and Control</orgName>
								<orgName type="institution" key="instit2">Samuel Oschin Comprehensive Cancer Institute</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA (MTG</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff92">
								<orgName type="department" key="dep1">Department of Biomedical Sciences</orgName>
								<orgName type="department" key="dep2">Cedars-Sinai Medical Center</orgName>
								<orgName type="institution">PJT); Community and Population Health Research Institute</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff93">
								<orgName type="department" key="dep1">Clinical Epidemiology and Aging Research</orgName>
								<orgName type="department" key="dep2">German Cancer Consortium (DKTK)</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<settlement>Heidelberg, Germany (HBre)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff94">
								<orgName type="department" key="dep1">Division of Health Sciences</orgName>
								<orgName type="department" key="dep2">Warwick Medical School</orgName>
								<orgName type="institution">German Cancer Research Center</orgName>
								<address>
									<addrLine>HBra)</addrLine>
									<settlement>Heidelberg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff95">
								<orgName type="department" key="dep1">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="department" key="dep2">Division of Tumor Genetics</orgName>
								<orgName type="laboratory">Klinikum Rechts der Isar</orgName>
								<orgName type="institution">Warwick University</orgName>
								<address>
									<settlement>Coventry</settlement>
									<region>UK (KB)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff96">
								<orgName type="department">Center for Integrated Oncology</orgName>
								<orgName type="institution">Technical University of Munich</orgName>
								<address>
									<settlement>Munich, Germany (AMe)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff97">
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff98">
								<orgName type="department" key="dep1">EHah, BW)</orgName>
								<orgName type="department" key="dep2">Center for Molecular Medicine</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff99">
								<orgName type="department" key="dep1">EHah, BW)</orgName>
								<orgName type="department" key="dep2">Center for Familial Breast and Ovarian Cancer</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff100">
								<orgName type="department" key="dep1">EHah, BW)</orgName>
								<orgName type="department" key="dep2">Department of Gynaecology and Obstetrics</orgName>
								<orgName type="department" key="dep3">Institute of Clinical Pharmacology</orgName>
								<orgName type="institution">University Hospital of Cologne</orgName>
								<address>
									<addrLine>Germany (BW); Dr. Margarete Fischer-Bosch</addrLine>
									<settlement>Cologne, Stuttgart</settlement>
									<country>Germany (HBra</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff101">
								<orgName type="department">Institute for Prevention and Occupational Medicine of the German Social Accident Insurance and Institute</orgName>
								<orgName type="institution">University of Tübingen</orgName>
								<address>
									<settlement>Tübingen</settlement>
									<country>Germany (HBra</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff102">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution">Ruhr University Bochum (IPA)</orgName>
								<address>
									<settlement>Bochum</settlement>
									<region>Germany (TB)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff103">
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<region>Finland (CB)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff104">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff105">
								<orgName type="department" key="dep1">Department of Clinical Genetics</orgName>
								<orgName type="department" key="dep2">Department of Pathology</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<region>KA)</region>
									<country>Finland (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff106">
								<orgName type="laboratory">Gynaecology Research Unit</orgName>
								<orgName type="institution">University of Helsinki and Helsinki University Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country>Finland (RB</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff107">
								<orgName type="department" key="dep1">TD)</orgName>
								<orgName type="department" key="dep2">Department of Molecular Medicine and Surgery</orgName>
								<orgName type="institution">Hannover Medical School</orgName>
								<address>
									<settlement>Hannover, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff108">
								<orgName type="department">Department of Oncology-Pathology</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm, Sweden (AL)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff109">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<country>Sweden (SMar</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff110">
								<orgName type="department" key="dep1">School of Medicine</orgName>
								<orgName type="department" key="dep2">Institute of Clinical Medicine, Pathology and Forensic Medicine</orgName>
								<orgName type="institution">Karolinska University Hospital</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<region>JR)</region>
									<country>Sweden (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff111">
								<orgName type="department">Department of Clinical Pathology</orgName>
								<orgName type="institution">University of Eastern Finland</orgName>
								<address>
									<addrLine>AMa); Imaging Center</addrLine>
									<settlement>Kuopio</settlement>
									<country>Finland (VMK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff112">
								<orgName type="department">Cancer Center</orgName>
								<orgName type="institution">Kuopio University Hospital</orgName>
								<address>
									<settlement>Kuopio</settlement>
									<country>Finland (VMK, AMa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff113">
								<orgName type="laboratory">VMK, AMa)</orgName>
								<orgName type="institution">Kuopio University Hospital</orgName>
								<address>
									<settlement>Kuopio</settlement>
									<country>Finland (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff114">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="laboratory">Laboratory for Translational Genetics</orgName>
								<orgName type="institution" key="instit1">Vesalius Research Center (VRC)</orgName>
								<orgName type="institution" key="instit2">VIB</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country>Belgium (DLa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff115">
								<orgName type="department" key="dep1">Multidisciplinary Breast Center</orgName>
								<orgName type="department" key="dep2">Department of Oncology</orgName>
								<orgName type="institution">University of Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country>Belgium (DLa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff116">
								<orgName type="department">Center for Medical Genetics</orgName>
								<orgName type="institution">University Hospitals Leuven</orgName>
								<address>
									<settlement>Leuven</settlement>
									<country key="BE">Belgium</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff117">
								<orgName type="department">Institute of Medical Biometrics and Epidemiology</orgName>
								<orgName type="institution">Ghent University</orgName>
								<address>
									<addrLine>TVM)</addrLine>
									<settlement>Ghent</settlement>
									<country>Belgium (KBMC</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff118">
								<orgName type="department" key="dep1">Department of Cancer Epidemiology</orgName>
								<orgName type="department" key="dep2">Clinical Cancer Registry</orgName>
								<orgName type="institution">University Medical Center Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country>Germany (DFJ</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff119">
								<orgName type="department">Department of Gynecology and Gynecologic Oncology</orgName>
								<orgName type="institution">University Medical Center Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country>Germany (DFJ</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff120">
								<orgName type="department" key="dep1">FH)</orgName>
								<orgName type="department" key="dep2">Department of Gynecology and Gynecologic Oncology</orgName>
								<orgName type="department" key="dep3">FH)</orgName>
								<orgName type="department" key="dep4">Institute of Human Genetics</orgName>
								<orgName type="institution">Kliniken Essen-Mitte/Evang. Huyssens-Stiftung/Knappschaft GmbH</orgName>
								<address>
									<addrLine>Dr. Horst Schmidt Kliniken Wiesbaden, Campus Virchov Klinikum</addrLine>
									<settlement>Essen, Wiesbaden, Charite Berlin</settlement>
									<country>Germany (, Germany (, Germany (RVM</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff121">
								<orgName type="department">Department of Preventive and Predictive Medicine</orgName>
								<orgName type="laboratory">Unit of Molecular Bases of Genetic Risk and Genetic Testing</orgName>
								<orgName type="institution" key="instit1">IFOM</orgName>
								<orgName type="institution" key="instit2">Fondazione Istituto FIRC di Oncologia Molecolare</orgName>
								<address>
									<settlement>Milan</settlement>
									<region>Italy (PP)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff122">
								<orgName type="department">Division of Experimental Oncology</orgName>
								<orgName type="institution">Fondazione IRCCS Istituto Nazionale dei Tumori</orgName>
								<address>
									<settlement>Milan</settlement>
									<region>Italy (PR)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff123">
								<orgName type="department">Division of Cancer Prevention and Genetics</orgName>
								<orgName type="institution">CRO (Centro di Riferimento Oncologico) Aviano National Cancer Institute</orgName>
								<address>
									<settlement>Aviano</settlement>
									<region>AV)</region>
									<country>Italy (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff124">
								<orgName type="department">Department of Preventive and Predictive Medicine</orgName>
								<orgName type="laboratory">Unit of Medical Genetics</orgName>
								<orgName type="institution">Istituto Europeo di Oncologia</orgName>
								<address>
									<settlement>Milan</settlement>
									<region>Italy (MB)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff125">
								<orgName type="department">Italy (BP, SMan); Immunology and Molecular Oncology Unit</orgName>
								<orgName type="institution">Fondazione IRCCS Istituto Nazionale Tumori</orgName>
								<address>
									<settlement>Milan</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff126">
								<orgName type="institution">Veneto Institute of Oncology IOV-IRCCS</orgName>
								<address>
									<settlement>Padua</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff127">
								<orgName type="department">Department of Genetics</orgName>
								<orgName type="institution">ULSS5 Ovest Vicentino</orgName>
								<address>
									<settlement>Italy</settlement>
									<region>CO</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff128">
								<orgName type="department">Biomedical Sciences Institute (ICBAS)</orgName>
								<orgName type="institution">Portugese Oncology Institute</orgName>
								<address>
									<settlement>Porto</settlement>
									<region>AP, MRT)</region>
									<country key="PT">Portugal</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff129">
								<orgName type="department" key="dep1">Section of Genetic Oncology</orgName>
								<orgName type="department" key="dep2">Department of Laboratory Medicine</orgName>
								<orgName type="institution">University of Porto</orgName>
								<address>
									<settlement>Porto</settlement>
									<country>Portugal (MRT</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff130">
								<orgName type="department">Department of Health Sciences Research</orgName>
								<orgName type="institution">University and University Hospital of Pisa</orgName>
								<address>
									<settlement>Pisa</settlement>
									<country>Italy (ACol</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff131">
								<orgName type="institution">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>MN (EHal</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff132">
								<orgName type="department" key="dep1">FJC)</orgName>
								<orgName type="department" key="dep2">Department of Laboratory Medicine and Pathology</orgName>
								<orgName type="institution" key="instit1">JEO, ELG</orgName>
								<orgName type="institution" key="instit2">Mayo Clinic</orgName>
								<address>
									<settlement>Rochester</settlement>
									<region>SNH, SS, MN (HSh</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff133">
								<orgName type="department">Division of Clinical Epidemiology</orgName>
								<orgName type="institution">JMC, FJC); Prince of Wales Hospital</orgName>
								<address>
									<settlement>Randwick, Sydney</settlement>
									<region>KT)</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff134">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="laboratory">MSG</orgName>
								<orgName type="institution" key="instit1">Royal Victoria Hospital</orgName>
								<orgName type="institution" key="instit2">McGill University</orgName>
								<address>
									<settlement>Montreal</settlement>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff135">
								<orgName type="department">Departments of Human Genetics and Oncology</orgName>
								<orgName type="laboratory">Program in Cancer Genetics</orgName>
								<orgName type="institution">McGill University</orgName>
								<address>
									<settlement>Montreal</settlement>
									<region>Canada (MSG)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff136">
								<orgName type="institution">McGill University</orgName>
								<address>
									<settlement>Montreal</settlement>
									<region>Quebec</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff137">
								<orgName type="institution">Medical School Cambridge University</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<region>England (MTi)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff138">
								<orgName type="institution" key="instit1">Centre Hospitalier Universitaire de Québec Research Center</orgName>
								<orgName type="institution" key="instit2">Laval University</orgName>
								<address>
									<settlement>Quebec</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff139">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">Canada (JSi, PS)</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff140">
								<orgName type="department">DME)</orgName>
								<orgName type="institution">University of Southampton</orgName>
								<address>
									<settlement>Southampton</settlement>
									<country>UK (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff141">
								<orgName type="department" key="dep1">Department of Genetics</orgName>
								<orgName type="department" key="dep2">Institute for Cancer Research</orgName>
								<orgName type="institution" key="instit1">Cancer Control Research</orgName>
								<orgName type="institution" key="instit2">BC Cancer Agency</orgName>
								<address>
									<settlement>Vancouver</settlement>
									<region>NL)</region>
									<country>Canada (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff142">
								<orgName type="department" key="dep1">Institute of Clinical Medicine</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine</orgName>
								<orgName type="institution">Oslo University Hospital</orgName>
								<address>
									<settlement>Radiumhospitalet, Oslo</settlement>
									<region>Norway (ALBD, VK)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff143">
								<orgName type="department">Department of Clinical Molecular Biology</orgName>
								<orgName type="institution">University of Oslo</orgName>
								<address>
									<settlement>Oslo</settlement>
									<region>Norway (ALBD, VK)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff144">
								<orgName type="department">Department of Gynecology and Obstetrics</orgName>
								<orgName type="institution" key="instit1">Oslo University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Oslo</orgName>
								<address>
									<settlement>Oslo</settlement>
									<region>Norway (VK)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff145">
								<orgName type="institution">Haukeland University Hospital</orgName>
								<address>
									<settlement>Bergen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff146">
								<orgName type="department">Department of Clinical Science</orgName>
								<orgName type="laboratory">Centre for Cancer Biomarkers</orgName>
								<orgName type="institution" key="instit1">Norway (HBS, LB)</orgName>
								<orgName type="institution" key="instit2">University of Bergen</orgName>
								<address>
									<settlement>Bergen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff147">
								<orgName type="department">Department of Chronic Disease Epidemiology</orgName>
								<orgName type="institution">Norway (HBS, LB); Rutgers Cancer Institute of New Jersey</orgName>
								<address>
									<settlement>New Brunswick</settlement>
									<region>NJ (EVB)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff148">
								<orgName type="department" key="dep1">Division of Epidemiology</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="institution">Yale School of Public Health</orgName>
								<address>
									<addrLine>Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center</addrLine>
									<settlement>New Haven</settlement>
									<region>CT (HR)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff149">
								<orgName type="laboratory">ABF</orgName>
								<orgName type="institution">Vanderbilt University School of Medicine</orgName>
								<address>
									<settlement>Nashville</settlement>
									<region>TN (WZ, HC)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff150">
								<orgName type="department">Department of Clinical Chemistry and Biocenter Oulu</orgName>
								<orgName type="laboratory">Laboratory of Cancer Genetics and Tumor Biology</orgName>
								<orgName type="institution">University of Oulu</orgName>
								<address>
									<settlement>Oulu</settlement>
									<region>KP, RW)</region>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff151">
								<orgName type="laboratory">Laboratory of Cancer Genetics and Tumor Biology</orgName>
								<address>
									<country>Northern Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff152">
								<orgName type="department">RW)</orgName>
								<orgName type="laboratory">Laboratory Centre Nordlab</orgName>
								<address>
									<settlement>Oulu</settlement>
									<region>KP</region>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff153">
								<orgName type="department">Department of Surgical Oncology</orgName>
								<orgName type="institution">Erasmus University Medical Center</orgName>
								<address>
									<settlement>Rotterdam</settlement>
									<country>the Netherlands (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff154">
								<orgName type="department" key="dep1">RAEMT, LBK)</orgName>
								<orgName type="department" key="dep2">Department of Clinical Genetics</orgName>
								<orgName type="institution" key="instit1">Family Cancer Clinic</orgName>
								<orgName type="institution" key="instit2">Erasmus University Medical Center</orgName>
								<address>
									<settlement>Rotterdam</settlement>
									<country>the Netherlands (AMWvdO</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff155">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="laboratory">ILA, OCGN</orgName>
								<orgName type="institution" key="instit1">Ontario Cancer Genetics Network Fred A. Litwin Center for Cancer Genetics, Lunenfeld Research Institute</orgName>
								<orgName type="institution" key="instit2">Mount Sinai Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff156">
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country>Canada (ILA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff157">
								<orgName type="department" key="dep1">Division of Epidemiology</orgName>
								<orgName type="department" key="dep2">Dalla Lana School of Public Health</orgName>
								<orgName type="institution" key="instit1">Prosserman Centre for Health Research</orgName>
								<orgName type="institution" key="instit2">Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country>Canada (JAK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff158">
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<country>Canada (JAK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff159">
								<orgName type="department">Department of Human Genetics</orgName>
								<orgName type="institution" key="instit1">Women&apos;s College Research Institute</orgName>
								<orgName type="institution" key="instit2">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff160">
								<orgName type="institution">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff161">
								<orgName type="department">Department of Pathology</orgName>
								<orgName type="institution" key="instit1">the Netherlands (PD)</orgName>
								<orgName type="institution" key="instit2">Leiden University Medical Center</orgName>
								<address>
									<settlement>Leiden</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff162">
								<orgName type="department" key="dep1">Division of Cancer Epidemiology and Genetics</orgName>
								<orgName type="department" key="dep2">Clinical Genetics Branch</orgName>
								<orgName type="department" key="dep3">Division of Cancer Epidemiology and Genetics</orgName>
								<orgName type="institution" key="instit1">the Netherlands (PD)</orgName>
								<orgName type="institution" key="instit2">National Cancer Institute</orgName>
								<address>
									<settlement>Rockville</settlement>
									<region>MD (JF)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff163">
								<orgName type="institution" key="instit1">National Cancer Institute</orgName>
								<orgName type="institution" key="instit2">National Institutes of Health</orgName>
								<address>
									<settlement>Rockville</settlement>
									<region>MD (MHG</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff164">
								<orgName type="department" key="dep1">Division of Genetics and Epidemiology</orgName>
								<orgName type="department" key="dep2">Institute of Cancer Research</orgName>
								<orgName type="institution">PLM, JTL)</orgName>
								<address>
									<settlement>London</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff165">
								<orgName type="department" key="dep1">Department of Medical Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">Institute of Cancer Sciences</orgName>
								<orgName type="institution" key="instit1">UK (MGC, MJS</orgName>
								<orgName type="institution" key="instit2">Karolinska Institutet</orgName>
								<address>
									<settlement>Stockholm</settlement>
									<region>MJ, AS), KC, HD, JLi, PH)</region>
									<country key="SE">Sweden</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff166">
								<orgName type="department" key="dep1">Wolfson Wohl Cancer Research Centre</orgName>
								<orgName type="department" key="dep2">Department of Gynaecological Oncology</orgName>
								<orgName type="institution" key="instit1">University of Glasgow</orgName>
								<orgName type="institution" key="instit2">Beatson Institute for Cancer Research</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff167">
								<orgName type="laboratory">Cancer Research UK Clinical Trials Unit</orgName>
								<orgName type="institution">Glasgow Royal Infirmary</orgName>
								<address>
									<settlement>Glasgow, Glasgow</settlement>
									<region>NS)</region>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff168">
								<orgName type="institution">Beatson West of Scotland Cancer Centre</orgName>
								<address>
									<settlement>Glasgow</settlement>
									<region>UK (RG)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff169">
								<orgName type="department" key="dep1">Cancer Genetics Center</orgName>
								<orgName type="department" key="dep2">Department of Surgery</orgName>
								<orgName type="institution" key="instit1">The Hong Kong Hereditary Breast Cancer Family Registry</orgName>
								<orgName type="institution" key="instit2">Hong Kong Sanatorium and Hospital</orgName>
								<address>
									<settlement>Hong Kong (AK)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff170">
								<orgName type="department">Department of Preventive Medicine</orgName>
								<orgName type="institution">University of Hong Kong</orgName>
								<address>
									<settlement>Hong Kong (AK)</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff171">
								<orgName type="institution">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff172">
								<orgName type="department">Department of Biomedical Science</orgName>
								<orgName type="institution" key="instit1">Republic of Korea (SKP)</orgName>
								<orgName type="institution" key="instit2">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country>Republic of Korea (SKP</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff173">
								<orgName type="institution" key="instit1">Cancer Research Institute</orgName>
								<orgName type="institution" key="instit2">Seoul National University College of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country>Republic of Korea (SKP</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff174">
								<orgName type="institution">Cancer Research Initiatives Foundation</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff175">
								<orgName type="department">SHT, SYY)</orgName>
								<orgName type="institution">Sime Darby Medical Centre</orgName>
								<address>
									<addrLine>Subang Jaya</addrLine>
									<settlement>Selangor</settlement>
									<country>Malaysia (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff176">
								<orgName type="department" key="dep1">Faculty of Medicine</orgName>
								<orgName type="department" key="dep2">Division of Molecular Medicine</orgName>
								<orgName type="institution" key="instit1">University Malaya Cancer Research Institute</orgName>
								<orgName type="institution" key="instit2">University Malaya Medical Centre</orgName>
								<address>
									<addrLine>University Malaya</addrLine>
									<settlement>Kuala Lumpur</settlement>
									<country>Malaysia (SYY</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff177">
								<orgName type="department">Division of Epidemiology and Prevention</orgName>
								<orgName type="institution">Aichi Cancer Center Research institute</orgName>
								<address>
									<settlement>Nagoya</settlement>
									<region>Aichi</region>
									<country>Japan (KMa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff178">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">Aichi Cancer Center Research Institute</orgName>
								<address>
									<settlement>Nagoya</settlement>
									<region>Aichi</region>
									<country>Japan (SHo</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff179">
								<orgName type="department">Department of Epidemiology</orgName>
								<orgName type="institution">University Malaya Medical Centre</orgName>
								<address>
									<addrLine>University Malaya</addrLine>
									<settlement>Kuala Lumpur</settlement>
									<country>Malaysia (YLW</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff180">
								<orgName type="department">Masaryk Memorial Cancer Institute and Medical Faculty</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
								<address>
									<settlement>Shanghai, Brno</settlement>
									<country>China (YTG</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff181">
								<orgName type="department">Department of Obstetrics and Gynecology, and Comprehensive Cancer Center</orgName>
								<orgName type="laboratory">Susanne Levy Gertner Oncogenetics Unit</orgName>
								<orgName type="institution" key="instit1">Czech Republic (LF)</orgName>
								<orgName type="institution" key="instit2">Medical University of Vienna</orgName>
								<address>
									<settlement>Vienna</settlement>
									<region>Australia (CFS, CRF)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff182">
								<orgName type="institution" key="instit1">Sheba Medical Center</orgName>
								<orgName type="institution" key="instit2">Tel-Hashomer</orgName>
								<address>
									<settlement>Israel</settlement>
									<region>EF, YL)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff183">
								<orgName type="department" key="dep1">Department of Community Medicine and Epidemiology</orgName>
								<orgName type="department" key="dep2">Carmel Medical Center and B. Rappaport Faculty of Medicine</orgName>
								<orgName type="department" key="dep3">N. N. Petrov Institute of Oncology</orgName>
								<orgName type="department" key="dep4">Center for Medical Genetics</orgName>
								<orgName type="institution">Clalit National Israeli Cancer Control Center</orgName>
								<address>
									<settlement>Haifa, St. Petersburg</settlement>
									<region>Israel (GR)</region>
									<country>Russia (ENI</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff184">
								<orgName type="department">Center for Clinical Cancer Genetics and Global Health</orgName>
								<orgName type="institution">NorthShore University Health System</orgName>
								<address>
									<settlement>Evanston</settlement>
									<region>IL (PJH)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff185">
								<orgName type="department">Division of Human Genetics</orgName>
								<orgName type="institution">University of Chicago Medical Center</orgName>
								<address>
									<settlement>Chicago</settlement>
									<region>IL (OIO)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff186">
								<orgName type="department" key="dep1">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep2">The Comprehensive Cancer Center</orgName>
								<orgName type="institution">The Ohio State University</orgName>
								<address>
									<settlement>Columbus</settlement>
									<region>OH (LS)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff187">
								<orgName type="department">Department of Molecular Genetics</orgName>
								<orgName type="institution">National Institute of Oncology</orgName>
								<address>
									<settlement>Budapest</settlement>
									<region>Hungary (EO)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff188">
								<orgName type="department" key="dep1">Department of Community and Family Medicine</orgName>
								<orgName type="department" key="dep2">Section of Biostatistics and Epidemiology</orgName>
								<orgName type="institution" key="instit1">Geisel School of Medicine</orgName>
								<orgName type="institution" key="instit2">Dartmouth College</orgName>
								<address>
									<settlement>Hanover</settlement>
									<region>NH (JAD)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff189">
								<orgName type="department">Department of Community and Family Medicine</orgName>
								<orgName type="institution">Duke University Medical Center</orgName>
								<address>
									<settlement>Durham</settlement>
									<region>NC (JSc)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff190">
								<orgName type="institution" key="instit1">Cancer Control and Population Sciences</orgName>
								<orgName type="institution" key="instit2">Duke Cancer Institute</orgName>
								<address>
									<settlement>Durham</settlement>
									<region>NC (JSc)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff191">
								<orgName type="laboratory">LAK)</orgName>
								<orgName type="institution" key="instit1">Radboud University Medical Center</orgName>
								<orgName type="institution" key="instit2">Radboud Institute for Health Sciences</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country>the Netherlands (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff192">
								<orgName type="department" key="dep1">Department of Gynaecology</orgName>
								<orgName type="department" key="dep2">Division of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep3">Department of Internal Medicine</orgName>
								<orgName type="laboratory">LFAGM)</orgName>
								<orgName type="institution" key="instit1">Radboud University Medical Center</orgName>
								<orgName type="institution" key="instit2">Radboud Institute for Molecular Life Sciences</orgName>
								<address>
									<settlement>Nijmegen</settlement>
									<country>the Netherlands (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff193">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of New Mexico</orgName>
								<address>
									<settlement>Albuquerque</settlement>
									<region>NM (LSC)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff194">
								<orgName type="institution">Oregon Health and Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR (TP)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff195">
								<orgName type="department">Department of Oncology</orgName>
								<orgName type="institution" key="instit1">Knight Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Oregon Health and Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR (TP)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff196">
								<orgName type="department">Department of Clinical Genetics</orgName>
								<orgName type="institution">Lund University</orgName>
								<address>
									<settlement>Lund</settlement>
									<country>Sweden (ABo</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff197">
								<orgName type="institution">Sahlgrenska University Hospital</orgName>
								<address>
									<settlement>Gothenburg</settlement>
									<country>Sweden (AÖ</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff198">
								<orgName type="department">Program in Epidemiology</orgName>
								<orgName type="institution">Fred Hutchinson Cancer Research Center</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>WA (MAR)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff199">
								<orgName type="department">Division of Cancer Epidemiology and Genetics</orgName>
								<orgName type="institution">National Cancer Institute</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>MD (NW)</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff200">
								<orgName type="department">Oncologic Centre</orgName>
								<orgName type="institution" key="instit1">Regional Tumour Registry</orgName>
								<orgName type="institution" key="instit2">Lund University Hospital</orgName>
								<address>
									<settlement>Lund</settlement>
									<region>KH)</region>
									<country>Sweden (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff201">
								<orgName type="department">Sheffield Cancer Research Department of Oncology</orgName>
								<orgName type="laboratory">Academic Unit of Pathology</orgName>
								<orgName type="institution">University of Sheffield</orgName>
								<address>
									<settlement>Sheffield</settlement>
									<country>UK (ACox</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff202">
								<orgName type="department">Department of Neuroscience</orgName>
								<orgName type="institution">University of Sheffield</orgName>
								<address>
									<settlement>Sheffield</settlement>
									<country>UK (SSC</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff203">
								<orgName type="department">Institute of Human Genetics</orgName>
								<orgName type="institution">Pontificia Universidad Javeriana</orgName>
								<address>
									<settlement>Bogota</settlement>
									<country>Colombia (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff204">
								<orgName type="department" key="dep1">DT)</orgName>
								<orgName type="department" key="dep2">Department of Genetics and Pathology</orgName>
								<orgName type="institution">Pomeranian Medical University</orgName>
								<address>
									<settlement>Szczecin, JLu</settlement>
									<region>AJa, JGr)</region>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff205">
								<orgName type="department">Department of Pathology and Laboratory Diagnostics</orgName>
								<orgName type="institution" key="instit1">Landspitali University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Iceland School of Medicine</orgName>
								<address>
									<settlement>Reykjavik</settlement>
									<country>Iceland (BAA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff206">
								<orgName type="department">Institute of Oncology</orgName>
								<orgName type="institution">the Maria Sklodowska-Curie Memorial Cancer Center</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<region>JK</region>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff207">
								<orgName type="department" key="dep1">Institute of Nuclear and Radiologic Sciences and Technology, Energy and Safety</orgName>
								<orgName type="department" key="dep2">FF, IK)</orgName>
								<orgName type="department" key="dep3">Department of Obstetrics and Gynecology</orgName>
								<orgName type="laboratory">Molecular Diagnostic Laboratory</orgName>
								<orgName type="institution" key="instit1">JMS)</orgName>
								<orgName type="institution" key="instit2">National Centre for Scientific Research Demokritos</orgName>
								<address>
									<settlement>Athens</settlement>
									<country>Greece (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff208">
								<orgName type="institution">Duke University Medical Center</orgName>
								<address>
									<settlement>Durham</settlement>
									<region>NC</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff209">
								<orgName type="department">Department of Dermatology</orgName>
								<orgName type="institution" key="instit1">Huntsman Cancer Institute</orgName>
								<orgName type="institution" key="instit2">University of Utah School of Medicine</orgName>
								<address>
									<addrLine>2000 Circle of Hope Drive</addrLine>
									<postCode>84112</postCode>
									<settlement>Salt Lake City</settlement>
									<region>UT</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-11-19">November 19, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">0583111A3F6F44A357363A5D56AFA16A</idno>
					<idno type="DOI">10.1093/jnci/djv315</idno>
					<note type="submission">Received: March 30, 2015; Revised: August 13, 2015; Accepted: October 2, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:35+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: The K3326X variant in BRCA2 (BRCA2*c.9976A&gt;T;</s><s>p.Lys3326*; rs11571833) has been found to be associated with small increased risks of breast cancer.</s><s>However, it is not clear to what extent linkage disequilibrium with fully pathogenic mutations might account for this association.</s><s>There is scant information about the effect of K3326X in other hormonerelated cancers.</s><s>Methods: Using weighted logistic regression, we analyzed data from the large iCOGS study including 76 637 cancer case patients and 83 796 control patients to estimate odds ratios (OR w ) and 95% confidence intervals (CIs) for K3326X variant carriers in relation to breast, ovarian, and prostate cancer risks, with weights defined as probability of not having a pathogenic BRCA2 variant.</s><s>Using Cox proportional hazards modeling, we also examined the associations of K3326X with breast and ovarian cancer risks among 7183 BRCA1 variant carriers.</s><s>All statistical tests were two-sided.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results:</head><p><s>The K3326X variant was associated with breast (OR w = 1.28, 95% CI = 1.17 to 1.40, P = 5.9x10 -6 ) and invasive ovarian cancer (OR w = 1.26, 95% CI = 1.10 to 1.43, P = 3.8x10 -3 ).</s><s>These associations were stronger for serous ovarian cancer and for estrogen receptor-negative breast cancer (OR w = 1.46, 95% CI = 1.2 to 1.70, P = 3.4x10 -5 and OR w = 1.50, 95% CI = 1.28 to 1.76, P = 4.1x10 -5 , respectively).</s><s>For BRCA1 mutation carriers, there was a statistically significant inverse association of the K3326X variant with risk of ovarian cancer (HR = 0.43, 95% CI = 0.22 to 0.84, P = .013)</s><s>but no association with breast cancer.</s><s>No association with prostate cancer was observed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>Our study provides evidence that the K3326X variant is associated with risk of developing breast and ovarian cancers independent of other pathogenic variants in BRCA2.</s><s>Further studies are needed to determine the biological mechanism of action responsible for these associations.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Inheritance of a pathogenic variant in BRCA2 is one of the strongest risk factors for breast and ovarian cancers <ref type="bibr" target="#b0">(1)</ref><ref type="bibr" target="#b1">(2)</ref><ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref>.</s><s>Estimates of the cumulative risk by age 70 years in BRCA2 variant carriers are 45% for breast cancer and 11% for ovarian cancer <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6)</ref>.</s><s>BRCA2 variants have also been shown to increase risk of prostate cancer <ref type="bibr" target="#b6">(7)</ref><ref type="bibr" target="#b7">(8)</ref><ref type="bibr" target="#b8">(9)</ref>, with the lifetime risk of prostate cancer in BRCA2 variant carriers estimated in the range of 19% to 34% <ref type="bibr" target="#b8">(9)</ref>.</s><s>In some studies, carriers of BRCA2 pathogenic variants also had increased risks of several other cancers, including pancreatic cancer <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11)</ref>, stomach cancer, and malignant melanoma <ref type="bibr" target="#b6">(7)</ref>.</s></p><p><s>BRCA2*c.9976A&gt;T; p.Lys3326*, hereafter referred to as K3326X, arises from a substitution of thymidine for adenine at nucleotide 9976 of the BRCA2 coding sequence and results in loss of the final 93 amino acids of the BRCA2 protein.</s><s>This premature stop codon was first described in 1996 by Mazoyer et al. <ref type="bibr" target="#b11">(12)</ref>, who found a minor allele frequency of about 1% in the control population and no increased prevalence of this sequence variant in patients with breast cancer; however, the study was small, with 462 control patients and 513 case patients.</s><s>Since then, the K3326X variant has been identified in individuals with various types of cancers, either alone or in combination with known pathogenic variants in BRCA2 <ref type="bibr" target="#b12">(13)</ref><ref type="bibr" target="#b13">(14)</ref><ref type="bibr" target="#b14">(15)</ref>.</s><s>Genome-wide association studies have identified the association between the K3326X variant and risk of squamous-cell lung cancer <ref type="bibr" target="#b15">(16)</ref> and breast cancer <ref type="bibr" target="#b16">(17)</ref> at genome-wide statistical significance levels, with odds ratios (ORs) of 2.47 (95% CI = 2.03 to 3.00, P = 4.7x10 -20 ) and 1.26 (95% CI = 1.14 to 1.39, P = 4.9x10 -8 ), respectively.</s><s>Recently, a large, pooled case-control study of cancers of the upper aero-digestive tract (UADT; including esophageal cancer) and the K3326X variant found that the K3326X variant was associated with UADT cancers (OR = 2.53, 95% CI = 1.89 to 3.38) <ref type="bibr" target="#b17">(18)</ref> as well, with a particularly strong effect for esophageal cancer (OR = 3.30, P = 3x10 -4 ).</s><s>K3326X is in linkage disequilibrium (LD) with the pathogenic variants BRCA2*c.6275_6276delTT</s><s>(formerly reported as 6503-6504delTT) and BRCA2*c.9257-16T&gt;C</s><s>(formerly reported as IVS 24-17T&gt;C) <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b13">14)</ref>.</s><s>In a study of 1850 high-risk breast and ovarian cancer UK families fully sequenced for BRCA2, Higgs et al. <ref type="bibr" target="#b18">(19)</ref> asserted that the association with increased breast cancer risk previously reported by Michailidou et al. <ref type="bibr" target="#b16">(17)</ref> was because of LD with BRCA2*c.6275_6276delTT and reported no associations with pancreatic, lung, or esophageal cancer risks, although the confidence intervals were wide and could not exclude the point estimates from the large-scale case-control studies cited above <ref type="bibr" target="#b15">(16,</ref><ref type="bibr" target="#b17">18)</ref>.</s></p><p><s>In this study, we therefore analyzed the association of the BRCA2 K3326X sequence variant with respect to risk of breast cancer, adjusting for potential effects of LD with known BRCA2 pathogenic variants, and for the first time examined the association between K3326X and ovarian and prostate cancer.</s><s>We further assessed whether K3326X is an independent modifier of breast and ovarian cancer risk in BRCA1 pathogenic variant carriers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>This study used data from the four consortia within the Collaborative Oncological Gene-Environment Study (COGS): the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), the Breast Cancer Association Consortium (BCAC), the Ovarian Cancer Association Consortium (OCAC), and the PRostate cancer AssoCiation group To Investigate Cancer Associated aLterations in the genome (PRACTICAL).</s><s>The COGS central focus was using data from high-throughput genotyping of large epidemiological studies, with state-of-the-art analysis and mathematical models to combine data on genetic and environmental/life style risk factors <ref type="bibr" target="#b19">(20)</ref>.</s><s>All studies had approval from the relevant ethics committees, and all participants gave informed consent.</s><s>Details on the numbers of participants in each consortium are shown in Table <ref type="table" target="#tab_1">1</ref>.</s></p><p><s>To validate the effect of the BRCA2 K3326X variant on ovarian cancer risk, we sequenced the BRCA2 gene in an independent sample of ovarian cancer case patients and control patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Fisher's exact statistics were calculated to assess associations between the K3326X variant and known BRCA2 pathogenic variants among study patients in CIMBA.</s><s>Using the datasets from the BCAC, OCAC, and PRACTICAL consortia, we evaluated the association of the BRCA2 K3326X variant with risks of breast, article invasive ovarian, and prostate cancer, respectively, through logistic regression models with adjustment for attained age, consortium study site, and principal components of population structure.</s><s>To examine the hypothesis that K3326X is associated with breast and ovarian cancers independently from BRCA2 pathogenic variants, we calculated and compared odds ratios using weighted logistic regression models (ie, OR w ), described below, and odds ratios using unweighted logistic regression models (ie, OR) using Wald Z-statistics.</s><s>Because of the lack of BRCA2 status in the BCAC and OCAC datasets, to account for possible LD with BRCA2 pathogenic variants we developed a model using the CIMBA dataset to predict whether case patients and control patients were carriers of pathogenic BRCA2 variants based on age at diagnosis (for case patients) and age at interview (for control patients) and carrier status at K3326X.</s><s>We then used this model to predict the probability of not having a pathogenic BRCA2 variant in the other datasets and used this as the weight in the logistic regression model.</s><s>This weight allowed us to adjust for the contribution of each patient to the test statistics based on their probability of not having a pathogenic BRCA2 variant.</s><s>Details of the calculation of these weights are shown in the Supplementary Methods (Available online).</s><s>Using a similar approach, we evaluated the association of the K3326X variant with breast cancer risk stratified by ER status, triple-negative status (ER-, PR-, and HER2-negative), and tumor morphology, specifically ductal and lobular.</s><s>We also evaluated the association of the K3326X variant with ovarian cancer risk stratified by histological subtypes of ovarian cancer, specifically serous, mucinous, endometrioid, and clear cell.</s><s>We used Z-statistics to determine whether or not the magnitude of the associations between the K3326X variant and breast cancer risk were statistically different across breast and ovarian cancer subtypes.</s><s>Using the datasets from the CIMBA consortium and Cox proportional hazards model, we examined the associations of the K3326X variant with breast and ovarian cancer risks for BRCA1 pathogenic variant carriers with censoring as defined in other CIMBA consortium analyses of data from the iCOGS study <ref type="bibr" target="#b20">(21)</ref>.</s><s>To account for the inclusion of multiple carriers from the same family, a robust variance approach clustering on family membership was used <ref type="bibr" target="#b21">(22)</ref>.</s><s>We tested the proportional-hazards assumption on the basis of Schoenfeld residuals.</s><s>Statistical analyses were performed in R (version 2.14.2) <ref type="bibr" target="#b22">(23)</ref>.</s><s>All statistical tests were two sided, with cutoff for statistical significance being .05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Homology-Directed Repair Assay</head><p><s>The HDR assay for BRCA2 has been described previously by Guidugli et al. <ref type="bibr" target="#b23">(24)</ref>.</s><s>Full-length flag-BRCA2 wild-type and mutant expression constructs were cotransfected with an I-Sce1 expressing pcBASce plasmid into BRCA2 deficient V-C8 cells, stably expressing the DR-GFP reporter plasmid.</s><s>HDR-dependent DNA double strand break was quantified by fluorescence-activated cell sorting (FACS) of GFP-positive cells after 72 hours.</s><s>Equivalent expression of wild-type and mutant BRCA2 proteins was confirmed by western blot analysis of anti-Flag-M2 (Sigma F1804) antibody immunoprecipitates from V-C8 cell lysates.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>In summary, 7183 BRCA1 mutation carriers and 5101 BRCA2 mutation carriers from CIMBA were used in the weight calculation; 76 637 cancer case patients and 83 796 control patients from BCAC, OCAC, and PRACTICAL were used in the main analysis.</s><s>Table <ref type="table" target="#tab_0">2</ref> shows the frequencies of the two most frequent BRCA2 pathogenic variants (c.6275_6276delTT and c.4889C&gt;G) among K3326X variant carriers in CIMBA.</s><s>The c.6275_6276delTT known pathogenic variant was identified in 233 of 306 K3326X variant carrier families carrying the K3326X variant and in 5/4795 K3326X variant noncarrier families (P &lt; .001),</s><s>and c.4889C&gt;G was observed in nine</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association Between the K3326X Variant and Breast Cancer Risk</head><p><s>Previous principal component analyses of these data derived six components used as adjustments for population structure in logistic regression models <ref type="bibr" target="#b16">(17)</ref>.</s><s>The analyses of K3326X and breast cancer are shown in Table <ref type="table" target="#tab_2">3</ref>.</s><s>The K3326X variant was associated with all invasive breast cancer (OR w = 1.28, 95% CI = 1.17 to 1.40, P = 5.9x10 -6 ), and this association was stronger for triple-negative breast cancer (OR w = 1.52, 95% CI = 1.18 to 1.92, P = 4.77x10 -3 ) and estrogen receptor-negative breast cancer (OR w = 1.50, 95% CI = 1.28 to 1.76, P = 4.10x10 -5 ).</s><s>Of note, the odds ratios adjusted for potential LD with known pathogenic BRCA2 variants were only slightly attenuated (eg, from 1.31 to 1.28 for all invasive breast cancer).</s><s>However, the weighted odds ratios were not statistically different between ER+ breast cancer data subsets and either ER-(P = .06)</s><s>or triple-negative breast cancer data subsets (P = .20),</s><s>which might be because of the small sample size of ER-(n = 158) and triple-negative breast cancer case patients (n = 53).</s><s>There was no evidence that K3326X was associated with lobular breast cancer (P = .70),</s><s>but the sample size of lobular breast cancer case patients among the K3326X variant carriers was relatively small (n = 67), and the association between K3326X and breast cancer was not statistically different between participants with ductal and lobular tumors (P = .17).</s></p><p><s>No association with breast cancer risk for BRCA1 pathogenic variant carriers was observed (HR = 1.00, 95% CI = 0.78 to 1.29, P = 1.00) (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association Between the K3326X Variant and Ovarian Cancer Risk</head><p><s>Previous principal component analyses derived five components used as adjustments for population structure in logistic regression models <ref type="bibr" target="#b24">(25)</ref>.</s><s>Adjusted weighted and unweighted odds ratios by histologic subtype of ovarian cancer are presented in Table <ref type="table" target="#tab_3">4</ref>.</s><s>The K3326X variant was present in 323 of 14 542 individuals (2.2%) with invasive ovarian cancer (OR = 1.29, 95% CI = 1.13 to 1.46, P = 1.41x10 -3 ; OR w = 1.26, 95% CI = 1.10 to 1.43, P = 3.84x10 -3 ) compared with 1.8% of control patients.</s><s>A statistically significant association of K3326X was observed with serous ovarian cancer (OR w = 1.46, 95% CI = 1.26 to 1.70, P = 3.44x10 -5 ).</s><s>However, little evidence was seen for an association of K3326X with nonserous ovarian cancer, although the sample size of such cancer case patients among the K3326X variant carriers was small (n = 60).</s><s>The weighted odds ratios were statistically different between serous ovarian cancer data subsets and nonserous ovarian cancer data subsets (P = 9.0x10 -4 ).</s><s>In contrast, among BRCA1 carriers, a statistically significantly decreased risk for K3326X variant carriers vs noncarriers was observed (HR = 0.43, 95% CI = 0.22 to 0.84, P = .013)</s><s>(data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Association Between the K3326X Variant and Prostate Cancer Risk</head><p><s>Previous principal component analyses derived six components used as adjustments for population structure in logistic regression models <ref type="bibr" target="#b25">(26)</ref>.</s><s>The K3326X variant was present in 358 of 21 014 case patients (1.7%) compared with 364 of 21 992 control patients (1.7%) (OR = 0.92, 95% CI = 0.77 to 1.09, P = .39;</s><s>OR w = 0.90, 95% CI = 0.76 to 1.07, P = .32).</s><s>We estimated that this study had 87.6% power to detect an odds ratio of 1.25 using a two-sided test, assuming that 1.7% of the population are K3326X carriers (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study, we confirmed that the BRCA2 K3326X variant is associated with increased risk of breast cancer independent of additional BRCA2 pathogenic variants and demonstrated an even stronger association with serous ovarian cancer.</s><s>These  <ref type="bibr" target="#b26">(27)</ref>.</s><s>More recent data (Exome Aggregation Consortium [ExAC], Cambridge, MA, http://exac.broadinstitute.</s><s>org) found the variant in 609 of 33 749 (1.8%) non-Finnish European sequenced individuals and a carrier frequency of 2.4% in Finland.</s><s>In our study, most K3326X carriers also carried the BRCA2*c9257-16T&gt;C variant, which is also consistent with previous studies <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b27">28)</ref>.</s><s>However, most individuals with BRCA2 pathogenic variants do not carry the K3326X variant, with the exception of individuals with c.6275_6276delTT and c.4889C&gt;G variants (Table <ref type="table" target="#tab_0">2</ref>).</s></p><p><s>The odds ratios obtained from unweighted logistic regression and weighted logistic regression were similar, suggesting that K3326X is associated with the risk of developing breast and ovarian cancers independently from BRCA2 known pathogenic variants (Tables <ref type="table" target="#tab_3">3 and 4</ref>).</s><s>The association of the K3326X variant with cancer risk was strongest in patients with triple-negative breast and serous ovarian tumors (OR w = 1.52, 95% CI = 1.18 to 1.92; and OR w = 1.46, 95% CI = 1.26 to 1.70, respectively).</s><s>ER-negative and triple-negative status has been linked to BRCA1 variants but not BRCA2 variants <ref type="bibr" target="#b28">(29)</ref><ref type="bibr" target="#b29">(30)</ref><ref type="bibr" target="#b30">(31)</ref><ref type="bibr" target="#b31">(32)</ref><ref type="bibr" target="#b32">(33)</ref><ref type="bibr" target="#b33">(34)</ref><ref type="bibr" target="#b34">(35)</ref>.</s><s>Because of these findings, BRCA1 tumors were hypothesized to have a different hormone-independent mechanism than BRCA2 tumors <ref type="bibr" target="#b32">(33)</ref>.</s><s>More research should explore the potential role of the BRCA2 K3326X variant in the etiology of these disease phenotypes.</s><s>Interestingly, the finding for serous ovarian cancer is consistent with epidemiological and genetic data showing that serous tumors have a different etiology from other ovarian carcinomas <ref type="bibr" target="#b35">(36)</ref><ref type="bibr" target="#b36">(37)</ref><ref type="bibr" target="#b37">(38)</ref>.</s><s>Notably, it is BRCA1 pathogenic variant carriers that generally have a higher risk of ER-breast and serous ovarian tumors, while there is no clear differential association for BRCA2 pathogenic variant carriers <ref type="bibr" target="#b32">(33)</ref>.</s><s>Overall, our results, together with evidence of molecular commonalities between triple-negative breast and high-grade serous ovarian tumors <ref type="bibr" target="#b38">(39)</ref>, suggest a possible related etiology between these two tumor subtypes.</s></p><p><s>Our study also provides other interesting findings that warrant further investigation.</s><s>First, the K3326X variant is associated with increased risks of breast and ovarian cancer in the general population; however, in BRCA1 variant carriers the K3326X variant is inversely associated with risk of ovarian cancer and not with risk of breast cancer.</s><s>Second, our study found no association between the K3326X variant and prostate cancer risk, in contrast to the increased risk of prostate cancer in carriers of BRCA2 pathogenic variants <ref type="bibr" target="#b43">(44)</ref><ref type="bibr" target="#b44">(45)</ref><ref type="bibr" target="#b45">(46)</ref><ref type="bibr" target="#b46">(47)</ref>.</s><s>The difference between the risk associations of K3326X and known BRCA2 pathogenic variants has been observed previously.</s><s>Wang et al. <ref type="bibr" target="#b15">(16)</ref> reported a more than two-fold increased squamous-cell lung carcinoma risk in K3326X variant carriers; however, to date, there has been no evidence of any altered risk of lung cancer in families carrying BRCA2 pathogenic variants <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b40">41)</ref>.</s><s>Additional studies are required to analyze the discrepant risk associations of the K3326X variant and other known BRCA2 pathogenic variants with prostate and lung cancer risks and whether the K3326X variant may have an association with cancer risk independent of other genes.</s><s>In contrast to lung cancer, there have been some reports of carriers of BRCA2 pathogenic variants having increased risk of some UADT cancers <ref type="bibr" target="#b39">(40,</ref><ref type="bibr" target="#b40">41)</ref>.</s></p><p><s>We can only speculate about how K3326X might affect key functions of the BRCA2 protein.</s><s>Fanconi anemia is an autosomal recessive disease characterized by cancer susceptibility, cellular hypersensitivity to DNA cross-linking agents, and other conditions <ref type="bibr" target="#b41">(42)</ref>.</s><s>FANCD2 encodes the protein for Fanconi anemia group D2 and is monoubiquitinated in response to DNA damage <ref type="bibr" target="#b42">(43)</ref>.</s><s>Interaction of monoubiquitinated FANCD2 and BRCA2 is essential for activation of the homologous recombination activity of RAD51, an important enzyme involved in DNA repair mechanisms, and for loading onto the damaged DNA <ref type="bibr" target="#b43">(44)</ref><ref type="bibr" target="#b44">(45)</ref><ref type="bibr" target="#b45">(46)</ref><ref type="bibr" target="#b46">(47)</ref><ref type="bibr" target="#b47">(48)</ref><ref type="bibr" target="#b48">(49)</ref>.</s><s>Cells that express BRCA2 protein lacking the C terminal exon 27 coding region do not show colocalization of FANCD2, BRCA2, and RAD51 on chromatin <ref type="bibr" target="#b43">(44,</ref><ref type="bibr" target="#b48">49)</ref>; mice with deletions of exon 27 and FANCD2 knockout mice had increased susceptibility to various types of cancers <ref type="bibr" target="#b49">(50)</ref>.</s><s>We hypothesize that the K3326X variant modifies breast and ovarian cancer risk by altering the C terminus of BRCA2, resulting in loss of the interaction between FANCD2 and BRCA2 and, thus, inactivating RAD51.</s><s>Our preliminary functional analyses showed that the average scaled HDR fold change for K3326X is 2.92 on a scale of 1 to 5, with a value of 5 for wild-type and 1 for BRCA2 pathogenic variant D2723H.</s><s>Although this value is significantly higher than known BRCA2 pathogenic mutations, it does fall slightly outside the range of neutral variants that have been observed to date <ref type="bibr" target="#b23">(24)</ref>.</s><s>It is possible that this reduced efficiency of HDR capacity is sufficient to cause the small increased breast and ovarian cancers risks described in this study.</s><s>Additional experiments are still being performed to demonstrate the role of the K3326X variant on the BRCA2 protein.</s></p><p><s>Our study is the largest study to date examining the association of the BRCA2 K3326X variant and breast, ovarian, and article prostate cancer risks.</s><s>The large sample size and the use of weighted logistic regression models allowed us to estimate the underlying association of K3326X with cancer risk independent of known BRCA2 pathogenic variants that are in LD with K3326X.</s><s>A limitation of our analysis was the lack of BRCA2 status in the BCAC and OCAC datasets, resulting in our use of the CIMBA BRCA2 dataset to calculate the probability of BRCA2 in order to create weights for the logistic regression models.</s><s>As shown in Tables <ref type="table" target="#tab_3">3 and 4</ref>, the effect of LD between K3326X and two BRCA2 pathogenic variants (ie, c.6275_6276delTT and c.4889C&gt;G) was quite small and did not materially change the results.</s><s>Therefore, it is extremely unlikely that the association with breast cancer can be explained by LD with BRCA2 pathogenic variants as hypothesized by Higgs et al. <ref type="bibr" target="#b18">(19)</ref>; we note that their conclusion is based on theoretical calculations and did not include a matched control dataset corresponding to the highly familial cases sequenced in the study.</s></p><p><s>In conclusion, our study provides evidence that the BRCA2*c.9976A&gt;T</s><s>(K3326X) variant contributes to the risk of developing breast and ovarian cancers.</s><s>It remains open whether the underlying mechanism for this association is identical to that for lung and UADT cancers; it is unlikely that this question can be resolved using genetic data alone.</s><s>Additional functional studies will be needed to determine the biological mechanism of action of the K3326X variant in the diverse set of cancers associated with it.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Frequencies of the two most frequent BRCA2 pathogenic variants that co-occurred with the K3326X common variant in the Consortium of Investigators of Modifiers of BRCA1/2</s></p></div></figDesc><table><row><cell>Human Genome Variation</cell><cell>BRCA2 K3326X</cell><cell>BRCA2 K3326X</cell><cell></cell></row><row><cell>Society nomenclature</cell><cell>noncarriers</cell><cell>carriers</cell><cell>P</cell></row><row><cell>c.6275_6276delTT</cell><cell>5</cell><cell>233</cell><cell>&lt;.001*</cell></row><row><cell>c.4889C&gt;G</cell><cell>0</cell><cell>9</cell><cell>&lt;.001*</cell></row><row><cell>Other BRCA2 known pathogenic variants †</cell><cell>4790</cell><cell>64</cell><cell>Reference</cell></row></table><note><p><s>* P values using two-sided Fisher's exact test calculated to assess the association between the K3326X variant and known BRCA2 pathogenic variants.</s><s>Each family in the Consortium of Investigators of Modifiers of BRCA1/2 was counted only once in this analysis.</s><s>† Listed in Supplementary Table 1 (available online).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>(13)er of control patients and breast cancer, ovarian cancer, and prostate cancer case patients included in the analysis The list and frequency of all pathogenic variants in the BRCA2 gene that co-occurred with the K3326X variant in CIMBA are shown in Supplementary Table1(available online).Within the BCAC dataset, among K3326X variant carriers, 1471 of 1490 individuals also harbored the BRCA2*c.9257-16T&gt;Cvariant,which was not considered pathogenic based on the low likelihood for splice site alteration(13).</s><s>Within the OCAC dataset, among K3326X variant carriers, all K3326X variant carriers also carried the BRCA2*c.9257-16T&gt;C</s><s>variant.</s><s>Within the independently sequenced set of ovarian cancer case patients and control patients, 2240 ovarian cancer case patients and 1530 control patients were included.</s><s>Twenty-seven K3326X carriers were found in the control patients, compared with 48 in the case patients (OR = 1.23, 95% CI = 0.70 to 2.00, P = .45),</s><s>and three of these carriers (all case patients) also carried the BRCA2*c.6275_6276delTT</s><s>pathogenic variant.</s></p></div></figDesc><table><row><cell>Study</cell><cell>Included in the analysis</cell></row><row><cell>The Consortium of</cell><cell>7183 BRCA1 mutation carriers,</cell></row><row><cell>Investigators of</cell><cell>of which 1658 were unaf-</cell></row><row><cell>Modifiers of BRCA1/2</cell><cell>fected, 2497 were breast</cell></row><row><cell>(CIMBA) (51)</cell><cell>cancer case patients, 543</cell></row><row><cell></cell><cell>were ovarian cancer case</cell></row><row><cell></cell><cell>patients, and 267 had both</cell></row><row><cell></cell><cell>breast and ovarian cancer</cell></row><row><cell></cell><cell>5101 BRCA2 mutation carriers,</cell></row><row><cell></cell><cell>of which 2183 were unaf-</cell></row><row><cell></cell><cell>fected, 2538 were breast</cell></row><row><cell></cell><cell>cancer case patients, 240</cell></row><row><cell></cell><cell>were ovarian cancer case</cell></row><row><cell></cell><cell>patients, and 140 had both</cell></row><row><cell></cell><cell>breast and ovarian cancer</cell></row><row><cell>Breast Cancer Association</cell><cell>41 081 breast cancer case</cell></row><row><cell>Consortium (BCAC) (52)</cell><cell>patients and 38 693 female</cell></row><row><cell></cell><cell>control patients</cell></row><row><cell>Ovarian Cancer</cell><cell>14 542 invasive ovarian can-</cell></row><row><cell>Association</cell><cell>cer case patients and 23 111</cell></row><row><cell>Consortium (OCAC) (53)</cell><cell>female control patients</cell></row><row><cell>PRostate cancer AssoCiation</cell><cell>21 014 prostate cancer case</cell></row><row><cell>group To Investigate</cell><cell>patients and 21 992 male</cell></row><row><cell>Cancer Associated</cell><cell>control patients</cell></row><row><cell>aLterations in the genome</cell><cell></cell></row><row><cell>(PRACTICAL) (54)</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Association between BRCA2 K3326X variant and risk of breast cancer (BC) by tumor subtypes: Breast Cancer Association Consortium</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Number of</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>No. of</cell><cell>K3326X carriers</cell><cell></cell><cell></cell><cell>Weighted</cell><cell></cell></row><row><cell>Subtypes</cell><cell>BC cases</cell><cell>in BC cases</cell><cell>OR (95% CI)*</cell><cell>P for OR</cell><cell>OR w (95% CI)*, †</cell><cell>P for OR w  ‡</cell></row><row><cell>Control women</cell><cell>38 693</cell><cell>637</cell><cell>1.00 (Ref)</cell><cell></cell><cell>1.00 (Ref)</cell><cell></cell></row><row><cell>Invasive BC cases</cell><cell>41 081</cell><cell>852</cell><cell>1.31 (1.20 to 1.43)</cell><cell>6.05x10 -7</cell><cell>1.28 (1.17 to 1.40)</cell><cell>5.86x10 -6</cell></row><row><cell>ER-</cell><cell>6441</cell><cell>158</cell><cell>1.54 (1.31 to 1.79)</cell><cell>5.07x10 -6</cell><cell>1.50 (1.28 to 1.76)</cell><cell>4.10x10 -5</cell></row><row><cell>ER+</cell><cell>24 833</cell><cell>501</cell><cell>1.28 (1.15 to 1.42)</cell><cell>8.50x10 -5</cell><cell>1.25 (1.13 to 1.39)</cell><cell>2.29x10 -4</cell></row><row><cell>Triple-negative</cell><cell>2158</cell><cell>53</cell><cell>1.55 (1.22 to 1.96)</cell><cell>2.45x10 -3</cell><cell>1.52 (1.18 to 1.92)</cell><cell>4.77x10 -3</cell></row><row><cell>Ductal</cell><cell>21 490</cell><cell>466</cell><cell>1.33 (1.20 to 1.48)</cell><cell>3.38x10 -6</cell><cell>1.30 (1.18 to 1.44)</cell><cell>2.17x10 -5</cell></row><row><cell>Lobular</cell><cell>3752</cell><cell>67</cell><cell>1.07 (0.87 to 1.32)</cell><cell>.57</cell><cell>1.05 (0.85 to 1.29)</cell><cell>.70</cell></row></table><note><p><s>* Adjusted for attained age (at interview for control patients and at diagnosis for case patients), principal components of European population structure, and study site.</s><s>CI = confidence interval; ER = estrogen receptor; OR = odds ratio.</s><s>† Calculated using weighted logistic regression models.</s><s>The weight applied for the i th individual in the Breast Cancer Association Consortium dataset is (1 -Probability of K3326X carriage and harboring known pathogenic variants in BRCA2).</s><s>‡ P values calculated using a two-sided Wald test.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Association between BRCA2 K3326X variant and risk of ovarian cancer (OC) by histological subtype: Ovarian Cancer Association Consortium In total, 2129 case patients did not have information on ovarian cancer histologic type.</s><s>CI = confidence interval; OR = odds ratio; Ref = reference.</s><s>† Adjusted for attained age (at interview for control patients and at diagnosis for case patients), principal component of European population structure, and study site.</s><s>‡ Calculated using weighted logistic regression models.</s><s>The weight applied for the k th individual in the Ovarian Cancer Association Consortium dataset is (1 -Probability of K3326X carriage and harboring known pathogenic variants in BRCA2).</s><s>§ P values calculated using a two-sided Wald test.</s></p></div></figDesc><table><row><cell></cell><cell>No. of</cell><cell>No. of K3326X</cell><cell></cell><cell></cell><cell>Weighted OR w</cell><cell></cell></row><row><cell>Subtype</cell><cell>OC cases*</cell><cell>carriers in BC cases</cell><cell>OR (95% CI) †</cell><cell>P for OR</cell><cell>(95% CI) †, ‡</cell><cell>P for OR w  §</cell></row><row><cell>Control women</cell><cell>23 111</cell><cell>411</cell><cell>1.00 (Ref)</cell><cell></cell><cell>1.00 (Ref)</cell><cell></cell></row><row><cell>Invasive OC cases</cell><cell>14 514</cell><cell>322</cell><cell>1.29 (1.13 to 1.46)</cell><cell>1.41x10 -3</cell><cell>1.26 (1.10 to 1.43)</cell><cell>3.84x10 -3</cell></row><row><cell>Serous</cell><cell>8360</cell><cell>210</cell><cell>1.50 (1.29 to 1.74)</cell><cell>9.21x10 -6</cell><cell>1.46 (1.26 to 1.70)</cell><cell>3.44x10 -5</cell></row><row><cell>Nonserous</cell><cell>4031</cell><cell>60</cell><cell>0.83 (0.65 to 1.04)</cell><cell>.18</cell><cell>0.81 (0.63 to 1.02)</cell><cell>.14</cell></row><row><cell>Mucinous</cell><cell>943</cell><cell>16</cell><cell>0.93 (0.59 to 1.39)</cell><cell>.79</cell><cell>0.91 (0.58 to 1.37)</cell><cell>.72</cell></row><row><cell>Endometrioid</cell><cell>2066</cell><cell>31</cell><cell>0.82 (0.59 to 1.11)</cell><cell>.31</cell><cell>0.81 (0.58 to 1.10)</cell><cell>.27</cell></row><row><cell>Clear cell</cell><cell>1022</cell><cell>13</cell><cell>0.72 (0.44 to 1.12)</cell><cell>.26</cell><cell>0.71 (0.42 to 1.10)</cell><cell>.23</cell></row></table><note><p><s>*</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Notes</head><p><s>This study would not have been possible without the contributions of the following: Per Hall (COGS); Douglas F.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This work was supported by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research and the Ministère de l'Économie, <ref type="bibr">de</ref></s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Brohet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Velthuizen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Hogervorst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="98" to="107" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Tavtigian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Simard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rommens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="333" to="337" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Identification of the breast cancer susceptibility gene BRCA2</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wooster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bignell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lancaster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">378</biblScope>
			<biblScope unit="issue">6559</biblScope>
			<biblScope unit="page" from="789" to="792" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wooster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Neuhausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mangion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">265</biblScope>
			<biblScope unit="issue">5181</biblScope>
			<biblScope unit="page" from="2088" to="2090" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies</title>
		<author>
			<persName><forename type="first">A</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Pharoah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Narod</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1117" to="1130" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stratton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="676" to="689" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations</title>
		<author>
			<persName><forename type="first">A</forename><surname>Moran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>O'hara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Fam Cancer</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="235" to="242" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Risch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Cole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Canada. J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="1694" to="1706" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium</title>
		<author>
			<persName><forename type="first">D</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Szabo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mangion</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="827" to="831" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers</title>
		<author>
			<persName><forename type="first">J</forename><surname>Iqbal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ragone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lubinski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2005" to="2009" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Risk of pancreatic cancer in breast cancer families from the breast cancer family registry</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mocci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Milne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Mendez-Villamil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="803" to="811" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">A polymorphic stop codon in BRCA2</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mazoyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Dunning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Serova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="253" to="254" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2</title>
		<author>
			<persName><forename type="first">K</forename><surname>Claes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Poppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Machackova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="314" to="320" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Haraldsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Loman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">X</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1367" to="1371" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Krainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Silva-Arrieta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Fitzgerald</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">336</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="1416" to="1421" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Mckay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rafnar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="736" to="741" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Large-scale genotyping identifies 41 new loci associated with breast cancer risk</title>
		<author>
			<persName><forename type="first">K</forename><surname>Michailidou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gonzalez-Neira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="361" to="e361" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">A rare truncating BRCA2 variant and genetic susceptibility to squamous cell cancers of upper aerodigestive tract</title>
		<author>
			<persName><forename type="first">M</forename><surname>Delahaye-Sourdeix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Anantharaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Timofeeva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst Monogr</title>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">The BRCA2 polymorphic stop codon: stuff or nonsense</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Higgs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Harkness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Bowers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="642" to="645" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Turning of COGS moves forward findings for hormonally mediated cancers</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Sakoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Jorgenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Witte</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="345" to="348" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gaudet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vijai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e1003173</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">A note on robust variance estimation for cluster-correlated data</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrics</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="645" to="646" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">R: A language and environment for statistical computing</title>
		<author>
			<persName><forename type="first">R</forename><surname>Development Core</surname></persName>
		</author>
		<author>
			<persName><surname>Team</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">R Foundation for Statistical Computing</title>
				<meeting><address><addrLine>Vienna, Austria</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity</title>
		<author>
			<persName><forename type="first">L</forename><surname>Guidugli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Pankratz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="265" to="275" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Pharoah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ramus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="370" to="e371" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Eeles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Olama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Benlloch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="391" to="e391" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A haplotype map of the human genome</title>
		<author>
			<persName><forename type="first">International</forename><surname>Hapmap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">437</biblScope>
			<biblScope unit="issue">7063</biblScope>
			<biblScope unit="page" from="1299" to="1320" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Matsubayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Rogers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="3652" to="3656" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Atchley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Albarracin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lopez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="4282" to="4288" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer</title>
		<author>
			<persName><forename type="first">F</forename><surname>Eisinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stoppa-Lyonnet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Longy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="471" to="474" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Foulkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Stefansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Chappuis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="1482" to="1485" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Karp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Tonin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Begin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="435" to="441" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Lakhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Van De Vijver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jacquemier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2310" to="2318" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main">HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Quenneville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ozcelik</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2002">2002</date>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="2068" to="2075" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">BRCA-associated breast cancer in young women</title>
		<author>
			<persName><forename type="first">M</forename><surname>Robson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gilewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Haas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1642" to="1649" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Shih Ie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kurman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1511" to="1518" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Risch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Marrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="363" to="372" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Early events in the pathogenesis of epithelial ovarian cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Landen</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Birrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Sood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="995" to="1005" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours</title>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">490</biblScope>
			<biblScope unit="issue">7418</biblScope>
			<biblScope unit="page" from="61" to="70" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Cancer risks in BRCA2 families: estimates for sites other than breast and ovary</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Van Asperen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Brohet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Meijers-Heijboer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="711" to="719" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Cancer risks in BRCA2 mutation carriers</title>
		<author>
			<persName><forename type="first">Bcl</forename><surname>Consortium</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1310" to="1316" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The emerging genetic and molecular basis of Fanconi anaemia</title>
		<author>
			<persName><forename type="first">H</forename><surname>Joenje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Patel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Genet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="446" to="457" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Molecular pathogenesis of Fanconi anemia: recent progress</title>
		<author>
			<persName><forename type="first">T</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'andrea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="4223" to="4233" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Homozygous germ line mutation in exon 27 of murine Brca2 disrupts the Fancd2-Brca2 pathway in the homologous recombination-mediated DNA interstrand cross-links&apos; repair but does not affect meiosis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Atanassov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Chromosomes Cancer</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="429" to="437" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mizuta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lasalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="6927" to="6932" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Emerging functions of BRCA2 in DNA recombination</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pellegrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Venkitaraman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Biochem Sci</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="310" to="316" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Insights into DNA recombination from the structure of a RAD51-BRCA2 complex</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pellegrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">420</biblScope>
			<biblScope unit="issue">6913</biblScope>
			<biblScope unit="page" from="287" to="293" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Shivji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">R</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Savill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="4000" to="4011" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Andreassen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'andrea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="5850" to="5862" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Mcallister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Houle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="990" to="994" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">RAD51 135G--&gt;C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Sinilnikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Simard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1186" to="1200" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium</title>
	</analytic>
	<monogr>
		<title level="j">Breast Cancer Association C</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="1382" to="1396" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>J Natl Cancer Inst</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schildkraut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Goode</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Clyde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2349" to="2357" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Kote-Jarai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Easton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Stanford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2052" to="2061" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
